CVRx, Inc. (CVRX) Investors Who Suffered Losses Are Encouraged to Contact Johnson Fistel Following Revenue Guidance Cut and Sales-Execution Disclosures

SAN DIEGO, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating whether CVRx, Inc. (NASDAQ: CVRX) or certain of its executive officers violated state or federal securities laws. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.

What if I purchased CVRx securities?
If you purchased CVRx securities and suffered losses on your investment, you may join our investigation now:

Click Here to Join the Investigation: https://www.johnsonfistel.com/investigations/cvrx/

Or for more information, contact James Baker at jimb@johnsonfistel.com or (619) 814-4471.

There is no cost or obligation to you.

What Is Johnson Fistel Investigating?
On August 6, 2026, CVRx lowered its full-year revenue guidance to $58 million–$60 million from $63 million–$67 million. Management stated: “This rapid pace of hiring has strained our onboarding and training processes and the ability of our area sales directors to spend the time necessary to accelerate these new team members up the productivity curve.” Management further stated: “The scale of the turnover, the slower pace of the territory manager productivity ramp, and the concentration of these new hires in a subset of our regions are the primary factors behind today’s guidance update.”

Management also stated that slightly less than half of CVRx’s regions, those with the highest turnover and least-tenured leaders, were experiencing negative year-to-date implant growth. CVRx also attributed its revised outlook in part to a prolonged challenge with one of its largest Medicare Advantage payers. The Company further disclosed that it received a Department of Justice civil investigative demand in May 2026 concerning certain sales and marketing practices.

Johnson Fistel is investigating whether CVRx or certain executives misrepresented or failed to timely disclose material information concerning sales-force execution, onboarding, reimbursement challenges, and the Company’s 2026 revenue outlook.

About Johnson Fistel, PLLP
Johnson Fistel, PLLP is a nationally recognized shareholder-rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in securities class actions and shareholder derivative litigation and also assists foreign investors who purchased securities on U.S. exchanges. To learn more, visit www.johnsonfistel.com.

Achievements
In 2024, Johnson Fistel was ranked among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services, reflecting the firm’s effectiveness in advocating for investors and recovering approximately $90,725,000 for clients in cases in which it served as lead or co-lead counsel.

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.

Contact:
Johnson Fistel, PLLP
501 W. Broadway, Suite 800
San Diego, CA 92101
James Baker, Investor Relations – or – Frank J. Johnson, Esq.
(619) 814-4471
jimb@johnsonfistel.com | fjohnson@johnsonfistel.com